Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STG320 in HDM-associated Allergic Rhinitis
NCT02443805Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Sep 2015
- Primary completion
- Jun 2018
- Modality
- Allergy Immunotherapy
- Countries
- 2
01
Overview
A Phase 3 trial of House dust mite allergen extract in allergic rhinitis (AR), sponsored by Stallergenes Greer. Started Sep 2015; status: completed.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02443805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443805.